Evidence map›Paper›PMID 32515353›Full record

ArticleeLife2020

G protein-regulated endocytic trafficking of adenylyl cyclase type 9.

André M Lazar, Roshanak Irannejad, Tanya A Baldwin, Aparna B Sundaram, J Silvio Gutkind, Asuka Inoue, Carmen W Dessauer, Mark Von Zastrow

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Adenylyl Cyclases as Therapeutic Targets in Neuroregeneration.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Review
  9. Pain Signaling by GPCRs and RTKs.Trends in pharmacological sciences · 2025
    Review
  10. Spatiotemporally Resolved Profiling of Protein Movement by TransitID.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

André M LazarProgram in Biochemistry and Cell Biology, University of California San Francisco, San Francisco, United States.ORCID 0000-0003-3372-3742
Roshanak IrannejadCardiovascular Research Institute and Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, United States.ORCID 0000-0001-8702-2285
Tanya A BaldwinDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, United States.
Aparna B SundaramLung Biology Center, Department of Medicine, University of California San Francisco, San Francisco, United States.ORCID 0000-0002-4076-4756
J Silvio GutkindDepartment of Pharmacology and Moores Cancer Center, University of California San Diego, San Diego, United States.
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan.
Carmen W DessauerDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, United States.
Mark Von ZastrowCardiovascular Research Institute and Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, United States.ORCID 0000-0003-1375-6926
University of California, San Francisco · USThe University of Texas Health Science Center at Houston · USTohoku University · JPUniversity of California San Diego · US

Funding

The Presynaptic Vesicle Cycle for the Slow Acting Neurotransmitter SecretionP01DA010154 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARDS, ROBERT H, KREITZER, ANATOL · 1995 to 2016
$14.7M
Using Networks to Seed Hierarchical Whole-cell Models of CancerU54CA209891 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2017 to 2021
$10.9M
PROTEINS REGULATING ENDOCYTOSIS OF OPIOID RECEPTORSR01DA012864 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark E Von Zastrow · 2000 to 2026
$7.9M
REGULATION OF ADENYLYL CYCLASE SIGNALING PATHWAYSR01GM060419 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DESSAUER, CARMEN W. · 2000 to 2021
$6.9M
Membrane Trafficking of Opioid and Adrenergic ReceptorsR01DA010711 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2014 to 2023
$4.6M
INVESTIGATION OF A NEWLY DISCOVERED ORGANELLE-BASED SIGNALING PARADIGMR35GM133521 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Roshanak Irannejad · 2019 to 2026
$3.3M
MEMBRANE TRAFFICKING OF OPIOID RECEPTORSR37DA010711 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2004 to 2013
$3.1M
Role of Human Chymase in Smooth Muscle Contraction in AsthmaK08HL124049 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SUNDARAM, APARNA BALA · 2015 to 2019
$822k
Role of endocytosis in beta-adrenergic receptors signaling in cardiomyocytesR00HL122508 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI IRANNEJAD, ROSHANAK · 2017 to 2019
$747k
MEMBRANE TRAFFICKING OF OPIOID RECEPTORSR29DA010711 · NIDA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI VON ZASTROW, MARK E. · 1997 to 2003
$413k
Role of endocytosis in beta-adrenergic receptors signaling in cardiomyocytesK99HL122508 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI IRANNEJAD, ROSHANAK · 2014 to 2015
$269k
NCI NIH HHS U54 CA209891NHLBI NIH HHS K08 HL124049NHLBI NIH HHS K99 HL122508NHLBI NIH HHS R00 HL122508NIDA NIH HHS P01 DA010154NIDA NIH HHS R01 DA010711NIDA NIH HHS R01 DA012864NIDA NIH HHS R29 DA010711NIDA NIH HHS R37 DA010711NIGMS NIH HHS R01 GM060419NIGMS NIH HHS R35 GM133521NIH HHS DA010154NIH HHS GM133521NIH HHS HL122508
6 · The paper itself

Abstract

GPCRs are increasingly recognized to initiate signaling via heterotrimeric G proteins as they move through the endocytic network, but little is known about how relevant G protein effectors are localized. Here we report selective trafficking of adenylyl cyclase type 9 (AC9) from the plasma membrane to endosomes while adenylyl cyclase type 1 (AC1) remains in the plasma membrane, and stimulation of AC9 trafficking by ligand-induced activation of Gs-coupled GPCRs. AC9 transits a similar, dynamin-dependent early endocytic pathway as ligand-activated GPCRs. However, unlike GPCR traffic control which requires β-arrestin but not Gs, AC9 traffic control requires Gs but not β-arrestin. We also show that AC9, but not AC1, mediates cAMP production stimulated by endogenous receptor activation in endosomes. These results reveal dynamic and isoform-specific trafficking of adenylyl cyclase in the endocytic network, and a discrete role of a heterotrimeric G protein in regulating the subcellular distribution of a relevant effector.

Indexed as

Adenylyl Cyclasesbeta-ArrestinsCell MembraneCyclic AMPEndosomesHumansProtein TransportReceptors, G-Protein-Coupledadenylate cyclase 9adenylyl cyclase 1Adenylyl Cyclasesbeta-ArrestinsCyclic AMPReceptors, G-Protein-Coupledadenyl cyclasecell biologycyclic AMPGPCRG proteinhumantrafficking

Identifiers

PMID32515353
PMCPMC7332294
OpenAlexW3033187819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.